Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0292106 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, 2023. Verfasst von Nicholas Winters und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: World Health Organization, Tuberculosis Epidemiologic Studies Consortium of CDC and by other CDC projects.
Abstract (Originalsprache)
Objective
Studying treatment duration for rifampicin-resistant and multidrug-resistant tuberculosis (MDR/RR-TB) using observational data is methodologically challenging. We aim to present a hypothesis generating approach to identify factors associated with shorter duration of treatment. Study design and setting We conducted an individual patient data meta-analysis among MDR/RR-TB patients restricted to only those with successful treatment outcomes. Using multivariable linear regression, we estimated associations and their 95% confidence intervals (CI) between the outcome of individual deviation in treatment duration (in months) from the mean duration of their treatment site and patient characteristics, drug resistance, and treatments used.
Results
Overall, 6702 patients with successful treatment outcomes from 84 treatment sites were included. We found that factors commonly associated with poor treatment outcomes were also associated with longer treatment durations, relative to the site mean duration. Use of bedaquiline was associated with a 0.51 (95% CI: 0.15, 0.87) month decrease in duration of treatment, which was consistent across subgroups, while MDR/RR-TB with fluoroquinolone resistance was associated with 0.78 (95% CI: 0.36, 1.21) months increase.
Conclusion
We describe a method to assess associations between clinical factors and treatment duration in observational studies of MDR/RR-TB patients, that may help identify patients who can benefit from shorter treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.
- Faculty of Pharmacy, Université de Montréal, Montreal, Canada.
- Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada.
- Department of Medicine & Department of Global and Public Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
- McGill International TB Centre, Montreal Chest Institute, Research Institute of the McGill University Health Centre, Montreal, Canada.
- Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada.
ORCID-Profile: Nicholas Winters, Nafees Ahmad, Margareth Pretti Dalcolmo
Förderung
- World Health Organization
- Tuberculosis Epidemiologic Studies Consortium of CDC and by other CDC projects
Zitieren
APA
Winters, N., Schnitzer, M. E., Campbell, J. R., Ripley, S., Winston, C., Savic, R., Ahmad, N., Bisson, G., Dheda, K., Esmail, A., Gegia, M., Monedero, I., Dalcolmo, M. P., Rodrigues, D., Singla, R., Yim, J. J., & Menzies, D. (2023). Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment. PLOS ONE. https://doi.org/10.1371/journal.pone.0292106
Vancouver
Winters N, Schnitzer ME, Campbell JR, Ripley S, Winston C, Savic R, et al. Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment. PLOS ONE. 2023. doi:10.1371/journal.pone.0292106
BibTeX
@article{Winters2023,
author = {Winters, Nicholas and Schnitzer, Mireille E and Campbell, Jonathon R and Ripley, Susannah and Winston, Carla and Savic, Rada and Ahmad, Nafees and Bisson, Gregory and Dheda, Keertan and Esmail, Ali and Gegia, Medea and Monedero, Ignacio and Dalcolmo, Margareth Pretti and Rodrigues, Denise and Singla, Rupak and Yim, Jae-Joon and Menzies, Dick},
title = {Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0292106}
}
EUVIMED